Determination of the long term diabetes related complications and cardiovascular events using UKPDS risk engine and UKPDS outcomes model in a representative western Indian population

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue SUPPL2, 2012, Pages

  Ghosh, Pinaki ^a   Kandhare, Amit D ^a   Raygude, Kiran S ^a   Kumar, V Shiva ^a   Rajmane, Anuchandra R ^a   Adil, Mohammad ^a   Bodhankar, Subhash L ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Diabetic complication; Modeling; Risk factors; UK Prospective Diabetes Study

Indexed keywords

ADULT; AMPUTATION; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; DEATH; DIABETES MELLITUS; DISEASE DURATION; FATALITY; FEMALE; FORECASTING; HEART FAILURE; HEART INFARCTION; HUMAN; INDIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; POPULATION RESEARCH; PRIORITY JOURNAL; SIMULATION; STATISTICAL MODEL; UK PROSPECTIVE DIABETES STUDY OUTCOMES MODEL; UK PROSPECTIVE DIABETES STUDY RISK ENGINE;

EID: 84871798338     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60237-0     Document Type: Article

References (90)

1. Sicree R, Shaw J, Zimmet P Diabetes and impaired glucose tolerance. Diabetes Atlas. International Diabetes Federation 2006, 15-103. Inter Diabetes Federation, Belgium. 3rd ed. D. Gan (Ed.).
2. Bagust A, McEwan P American Diabetes Association Consensus Panel: Guidelines for computer modeling of diabetes and its complications (Consensus Statement). Diabetes Care 2004, 27:2262-2265.
3. Wild S, Roglic G, Green A, Sicree R, King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
4. Baik S, Chacra AR, Yuxiu L, White J, Güler S, Latif ZA Conducting cost-effectiveness analyses of type 2 diabetes in low- and middle-income countries: can locally generated observational study data overcome methodological limitations?. Diabetes Res Clin Pract 2010, 88(Suppl 1):S17-S22.
5. Booth GL, Kapral MK, Fung K, Tu JV Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006, 368(9529):29-36.
6. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 2012, 83:650-659.
7. Song SH, Hardisty CA Early onset type 2 diabetes mellitus: a harbinger for complications in later years-clinical observation from a secondary care cohort. QJM 2009, 102(11):799-806.
8. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett 2012, 511:18-22.
9. Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacol 2012, 10.1007/s10787-012-0122-z.
10. Kirk JK, Bertoni AG, Case D, Bell RA, Goff DC, Narayan KM Predicted risk of coronary heart disease among persons with type 2 diabetes. Coron Artery Dis 2007, 18(8):595-600.
11. Yan Z, Liu Y, Huang H Association of glycosylated hemoglobin level with lipid ratio and individual lipids in type 2 diabetic patients. Asian Pac J Trop Med 2012, 5(6):469-471.
12. International diabetes federation Clinical guidelines taskforce. Global guideline for type 2 diabetes[article online], 2005 Last accessed 17 February 2006. http://www.idf.org/webdata/docs/idfggt2d.pdf.
13. Beckley ET New ADA initiative moves beyond 'metabolic syndrome'. Doc News 2006, 3:1-19.
14. Barton P, Andronis L, Briggs A, McPherson K, Capewell S Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ 2011, 343:d4044.
15. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002, 33(7):1776-1781.
16. Kwach B Mathematical Model for Detecting Diabetes in the Blood. App Math Sci 2011, 5(6):279-286.
17. Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, et al. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care 2009, 32(4):708-713.
18. van der Heijden AWA, Ortegon MM, Niessen LW, Nijpels G, Dekker JM Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population during 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk Functions the Hoorn Study. Diabetes care 2009, 32:2094-2098.
19. Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Aguilar-Salinas CA UKPDS Risk Engine, decode and diabetes PHD models for the estimation of cardiovascular risk in patients with diabetes. Curr Diabetes Rev 2010, 6(1):1-8.
20. Stevens RJ, Kothari V, Adler AI, Stratton IM United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001, 101(6):671-679.
21. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112(20):3066-3072.
22. Stevens R, Adler A, Gray A, Briggs A, Holman R Life-expectancy projection by modelling and computer simulation (UKPDS 46). Diabetes Res Clin Pract 2000, 50(Suppl 3):S5-13.
23. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32(2):287-294.
24. Datta S, Udupa AL Antihypertensive drug use in patients having comorbid diabetes: cross sectional prescription pattern study in a tertiary care hospital. Asian J Pharm Clinical Res 2010, 3(4):43-45.
25. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004, 47(10):1747-1759.
26. Gupta M, Brister S Is South Asian ethnicity an independent cardiovascular risk factor?. Can J Cardiol 2006, 22(3):193-197.
27. Boutayeb A, Chetouani A A critical review of mathematical models and data used in diabetology. Biomed Eng Online 2006, 5:43.
28. Kandhare AD, Raygude KS, Ghosh P, Gosavi TP, Bodhankar SL Patentability of Animal Models: India and the Globe. Int J Pharm Biol Arc 2011, 2(4):1024-1032.
29. Kumar A, Biswas UK, Nagtilak S, Ramiah S Lipid ratio useful indicator in predicting risk of myocardial infarction in elderly normolipidemic patients: a report from a multi center study. Asian Pac J Trop Dis 2011, 1(2):123-126.
30. Arjunan I, Gopinath D, Murthy NS Role of informal care providers in home based long term care in diabetesmellitus at Kaiwara Primary Health Center area, Karnataka, India. Asian Pac J Trop Dis 2011, 1(2):127-130.
31. Patil MVK, Kandhare AD, Bhise SD Evaluation of patient information leaflets on basis of consumer psychology and opinion. Int J Phar Pharm Sci Res 2011, 1(2):87-92.
32. Ramachandran A, Mary S, Yamuna A, Murugesan N, Snehalatha C High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008, 31(5):893-898.
33. Sullivan SD, Alfonso-Cristancho R, Conner C, Hammer M, Blonde L Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone. Cardiovasc Diabetol 2009, 8:12.
34. Saha S, Gerdtham UG, Johansson P Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health 2010, 7(8):3150-3195.
35. Viswanathan V, Kumpatla S Pattern and causes of amputation in diabetic patients-a multicentric study from India. J Assoc Physicians India 2011, 59:148-151.
36. Widatalla AH, Mahadi SE, Shawer MA, Elsayem HA, Ahmed ME Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation. Int J Diabetes Dev Ctries 2009, 29(1):1-5.
37. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001, 44(9):1094-1101.
38. Ramachandran A Epidemiology of diabetes in India-three decades of research. J Assoc Physicians India 2005, 53:34-38.
39. Kessler R, Keusch G, Szucs TD, Wittenborn JS, Hoerger TJ, Brügger U, et al. Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland. Swiss Med Wkly 2012, 142:w13508.
40. Rauner MS, Heidenberger K, Pesendorfer EM. Using a Markov model to evaluate the cost-effectiveness of diabetic foot prevention strategies in Austria, Proceedings of the Western Multiconference, International Conference on Health Sciences Simulation, January 18-22, 2004, San Diego, California, USA, The Society of Computer Simulation International, San Diego, USA, pp. 63-68.
41. Cobiac L, Vos T, Veerman L Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy Lifestyle program. Aust N Z J Public Health 2010, 34(3):240-247.
42. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010, 33(8):1872-1894.
43. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(7258):405-412.
44. Ghosh P, Kandhare AD, Shiva Kumar V., Rajmane AR, Mohammad Adil, Bodhankar SL Determination of clinical outcome and pharmacoeconomics of anti-rheumatoid arthritis therapy using CDAI, EQ-5D-3L and EQ-VAS as indices of disease amelioration. Asian Pac J Trop Dis 2012, In press. D157.
45. Ramesh A, Madhu S Influence of post discharge counseling on health outcomes in diabetic and hypertensive patients. Asian J Pharm Clin Res 2011, 4(3):28-33.
46. Kandhare AD, Raygude KS, Ghosh P, Gosavi TP, Bodhankar SL A comparative cross sectional descriptive study of individual pharmacy Vs mall pharmacies to evaluate customer satisfaction as well as purchasing behavior. Der Pharmacia Lettre 2011, 3(4):71-83.
47. Kalra S, Kalra B, Sharma A Prevalence of type 1 diabetes mellitus in Karnal district, Haryana state, India. Diabetol Metab Syndr 2010, 2:14.
48. Gosavi TP, Kandhare AD, Ghosh P, Bodhankar SL Anticonvulsant activity of Argentum metallicum, a homeopathic preparation. Der Pharmacia Lettre 2012, 4(2):626-637.
49. Patil MVK, Kandhare AD, Ghosh P, Bhise SD Determination of role of GABA and nitric oxide in anticonvulsant activity of Fragaria vesca L. ethanolic extract in chemically induced epilepsy in laboratory animals. Orient Pharm Exp Med 2012, In Press DOI 10.1007/s13596-012-0072-4.
50. Patel DK, Kumar R, Laloo D, Hemalatha S Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pac J Trop Biomed 2012, 2(5):411-420.
51. Williams-Herman D, Engel SS, Round E, Johnson J, Golm GT, Guo H, et al. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10, 246 patients with type 2 diabetes. BMC Endocr Disord 2010, 10:7.
52. Waugh N, Cummins E, Shyangdan D, Court R, Mohiuddin S. Evidence review group report: Long-acting exenatide in the management of type 2 diabetes. A Single Technology Appraisal. Warwick Evidence, 2011.
53. Chirakup S, Chaiyakunapruk N, Chaikledkeaw U, Pongcharoensuk P, Ongphiphadhanakul B, Roze S, et al. Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand. Value Health 2008, 11(Suppl 1):S43-S51.
54. Gonzalez JC, Walker JH, Einarson TR Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Publica 2009, 26(1):55-63.
55. Huang ES, Basu A, O'Grady M, Capretta JC Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 2009, 32(12):2225-2229.
56. Cameron C, Coyle D, Ur E, Klarenbach S Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ 2010, 182(1):28-34.
57. Saver BG, Hargraves JL, Mazor KM Are population-based diabetes models useful for individual risk estimation?. J Am Board Fam Med 2011, 24(4):399-406.
58. Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, et al. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010, 53(5):821-831.
59. Suleman N, Sarpong S Statistical modeling of hypertension cases in Navrongo, Ghana, West Africa. Am J Soc Mgmt Sci 2011, 2(4):377-383.
60. Ghosh P, Bodhankar SL Application of polymerase chain reaction for determination of prevalence of helicobacter pylori in salivary samples of asymptomatic subjects. Asian J Pharm Clinical Res 2011, 4(4):21-24.
61. Gosavi TP, Ghosh P, Kandhare AD, Bodhankar SL Unwrapping Homeopathic Principles in the Wake of Research: Serendipity, Placebo or True Therapeutic Milestones. Pharmacologyonline 2011, 1:894-906.
62. Nagpal J, Bhartia A Quality of diabetes care in the middle- and high-income group populace: the Delhi Diabetes Community (DEDICOM) survey. Diabetes Care 2006, 29(11):2341-2348.
63. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001, 25(11):1722-1729.
64. Gosavi TP, Kandhare AD, Raygude KS, Ghosh P, Bodhankar SL A comparative study on the efficacy, safety and cost effectiveness of Viscum album and Rauwolfia serpentina mother tincture in hypertensive patients. Deccan J. Natural Products 2011, 2(3):29-35.
65. Patil MVK, Kandhare AD, Bhise SD Anti-arthritic and anti-inflammatory activity of Xanthium srtumarium L. ethanolic extract in Freund's complete adjuvant induced arthritis. Biomed Aging Pathol 2012, 2:6-15.
66. Gosavi TP, Ghosh P, Kandhare AD, Bodhankar SL Therapeutic effect of H. pylori nosode in healing of chronic H. pylori infected ulcers in laboratory animals. Asian Pac J Trop Dis 2012, In press. D152.
67. Shini VK, Aboobacker S, Pahuja S, Revikumar KG, Bhasi R Pharmacoeconomic study of DMARDs in the management of rheumatoid arthritis. Int J Pharm Sci Rev Res 2010, 5(3):148-154.
68. Habib SH, Biswas KB, Akter S, Saha S, Ali L Cost-effectiveness analysis of medical intervention in patients with early detection of diabetic foot in a tertiary care hospital in Bangladesh. J Diabetes Complications 2010, 24(4):259-264.
69. Ghosh P, Bodhankar SL Association of smoking, alcohol and NSAIDs use with expression of cagA and cagT genes of Helicobacter pylori in salivary samples of asymptomatic subjects. Asian Pac J Trop Biomed 2012, 2(6):479-484.
70. Ghosh P, Bodhankar SL Determination of risk factors and transmission pathways of Helicobacter pylori in asymptomatic subjects in Western India using polymerase chain reaction. Asian Pac J Trop Dis 2012, 2(1):12-17.
71. Ghosh P, Kandhare AD, Gauba D, Raygude KS, Bodhankar SL Determination of efficacy, adverse drug reactions and cost effectiveness of three triple drug regimens for the treatment of H. pylori infected acid peptic disease patients. Asian Pac J Trop Biomed 2012, B62 In press.
72. Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, et al. Urban rural differences in prevalence of self-reported diabetes in India the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract 2008, 80(1):159-168.
73. Ghosh P, Bodhankar SL A Cross Sectional Study to Determine Association of the Socio Demographic Risk Factors with Prevalence and Virulence of H. pylori Infection in Salivary Samples of Asymptomatic Subjects by Application of Polymerase Chain Reaction Technique. Pharmacologia 2012, 3:481-489.
74. Ghosh P, Pandit VA, Karandikar Y, Diwan AG, Bodhankar SL A cross sectional study to determine risk factors associated with prevalence of H. pylori infection in salivary samples of acid peptic disease patients in western India. Pharmacologia 2012, 3(11):554-564.
75. Huxley R, Barzi F, Woodward M Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332(7533):73-78.
76. IDF clinical guidelines task force. Global guidelines for type 2 diabetes: Recommendations for standard, comprehensive and minimal care. Diab Med 2006, 23:579-593.
77. Indian council of medical research Guidelines for management of type 2 diabetes[article online] accessed 17 February 2006. http://www.icmr.nic.in/guidelines_diabetes/guide_diabetes.htm.
78. American diabetes association Standards of medical care in diabetes-2006. Diabetes Care 2006, 29:S4-S42.
79. Kandhare AD, Raygude KS, Ghosh P, Bodhankar SL The ameliorative effect of fisetin, a bioflavonoid, on ethanol-induced and pylorus ligation-induced gastric ulcer in rats. Int J Green Pharm 2011, 5:236-243.
80. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Gosavi TP, Badole SL, Bodhankar SL Effect of hydroalcoholic extract of Hibiscus rosa sinensis Linn. leaves in experimental colitis in rats. Asian Pac J Trop Biomed 2012, 5:337-344.
81. Patil MVK, Kandhare AD, Bhise SD Anti-inflammatory effect of Daucus carota root on experimental colitis in rats. Int J Pharm Pharm Sci 2012, 4(1):337-343.
82. Patil MVK, Kandhare AD, Bhise SD Effect of aqueous extract of Cucumis sativus Linn. fruit in ulcerative colitis in laboratory animals. Asian Pac J Trop Biomed 2012, 2(3):215-222.
83. Patil MVK, Kandhare AD, Bhise SD Pharmacological evaluation of ethanolic extract of Daucus carota Linn root formulated cream on wound healing using excision and incision wound model. Asian Pac J Trop Biomed 2012, S646-S655.
84. Patil MK, Kandhare AD, Bhise SD Pharmacological evaluation of ameliorative effect of aqueous extract of Cucumis sativus L. fruit formulation on wound healing in Wistar rats. Chron Young Sci 2011, 2:207-213.
85. Raygude KS, Kandhare AD, Ghosh P, Bodhankar SL Anticonvulsant effect of fisetin by modulation of endogenous biomarkers. Biomed Prev Nutr 2012, 2(3):215-222.
86. Raygude KS, Kandhare AD, Ghosh P, Gosavi TP, Bodhankar SL Consumption of Alcohol and H. pylori infection: A Cumulative Meta-Analysis of Literature. Asian J Biochem Pharm Res 2011, 3(1):338-345.
87. Ghosh P, Kandhare AD, Raygude KS, Gauba D, Gosavi TP, Bodhankar SL Cigarette smoking and H. pylori infection: A meta-analysis of literature. Der Pharmacia Lettre 2012, 4(1):128-134.
88. Gosavi TP, Kandhare AD, Raygude KS, Ghosh P, Bodhankar SL Evaluation of clinical outcome in arthritis with AIMS2. Deccan J Pharmacol 2011, 2(3):10-30.
89. Patil MVK, Kandhare AD, Bhise SD, Bhale S A comparative cross sectional descriptive market survey of various brands of Levofloxacin. Asian J Pharm Biol Res 2011, 1(2):174-181.
90. Hass B, Pooley J, Feuring M, Suvarna V, Harrington AE Health technology assessment and its role in the future development of the Indian healthcare sector. Perspect Clin Res 2012, 3(2):66-72.